ATP5IF1
ATPase inhibitor, mitochondrial
Also known as: ATIF1_HUMAN, ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UII2
- Gene
- ATP5IF1
- Ensembl
- ENSG00000130770
- Chromosome
- 1
- Canonical length
- 106 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Subcellular location
- Mitochondria
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Enables several functions, including ATPase binding activity; angiostatin binding activity; and mitochondrial proton-transporting ATP synthase complex binding activity. Involved in several processes, including mitochondrial depolarization; negative regulation of endothelial cell proliferation; and positive regulation of metabolic process. Located in cell surface and mitochondrion. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
106 residues, UniProt reviewed canonical sequence.
>Q9UII2|ATP5IF1
1 MAVTALAART WLGVWGVRTM QARGFGSDQS ENVDRGAGSI REAGGAFGKR EQAEEERYFR
61 AQSREQLAAL KKHHEEEIVH HKKEIERLQK EIERHKQKIK MLKHDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP5IF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 548 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 548 nTPM
- skeletal muscle: 437 nTPM
- amygdala: 406 nTPM
- hypothalamus: 382 nTPM
- cerebral cortex: 376 nTPM
- kidney: 373 nTPM
Single-cell type
- late primary spermatocytes: 2,589 nCPM
- early spermatids: 1,499 nCPM
- endometrial ciliated cells: 759 nCPM
- granulosa cells: 715 nCPM
- parietal cells: 705 nCPM
- enterocytes: 579 nCPM
Immune cell
- T-reg: 228 nTPM
- total PBMC: 215 nTPM
- plasmacytoid DC: 214 nTPM
- memory B-cell: 196 nTPM
- memory CD8 T-cell: 156 nTPM
- memory CD4 T-cell: 155 nTPM
Brain region
- cerebral cortex: 61 nTPM
- hypothalamus: 61 nTPM
- white matter: 56 nTPM
- medulla oblongata: 48 nTPM
- pons: 45 nTPM
- basal ganglia: 45 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.76
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- angiogenesis
- erythrocyte differentiation
- generation of precursor metabolites and energy
- heme biosynthetic process
- mitochondrial depolarization
- negative regulation of cardiac muscle cell apoptotic process
- negative regulation of endothelial cell proliferation
- negative regulation of hydrolase activity
- positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
- positive regulation of proteolysis involved in protein catabolic process
- positive regulation of type 2 mitophagy
- reactive oxygen species metabolic process
- regulation of ATP metabolic process
- regulation of protein targeting to mitochondrion
- response to ischemia
- negative regulation of mitochondrial ATP synthesis coupled proton transport
Molecular functions
- angiostatin binding
- ATPase binding
- ATPase inhibitor activity
- calmodulin binding
- enzyme binding
- enzyme inhibitor activity
- identical protein binding
- mitochondrial proton-transporting ATP synthase complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Mitochondrial ATPase inhibitor
- Mitochondrial ATPase inhibitor, IATP
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP5IF1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP5IF1 as an antibody target. Whether an autoantibody or antibody against ATP5IF1 could matter depends on whether native ATP5IF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP5IF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP5IF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...